You are here

Analytics & Quality


Researchers from Brigham and Women's Hospital in Boston have found digital pills could monitor opioid use after surgery, according to a study published in Anesthesia & Analgesia.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

Researchers from the University of Pennsylvania believe reviewing the social media of patients with attention-deficit/hyperactivity disorder (ADHD) could lead to the formation of improved treatments. Findings were published in the Journal of Attention Disorders.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a mathematical model capable of predicting how cancer patients will react to certain immunotherapies. Findings are explained in a study published in Nature.

As the number of individuals with type 2 diabetes increases, researchers search for a way to prevent or slow the progression of diabetes in at-risk patients. According to a study published in JMIR Diabetes, an artificial intelligence (AI) coaching platform could improve habits to prevent the onset of type 2 diabetes.


Recent Headlines

Practicing on 3D-printed models cuts surgery time, costs

Practicing before a surgery, especially for procedures on children, helps reduce surgery time and costs. In a study published in the Journal of Children's Orthopaedics, engineers and pediatric orthopedic surgeons have utilized 3D printing to help surgeons train for a common hip disorder in children 9 to 16 that cuts surgery times by 25 percent.

Patients more interested in hospital websites, mobile usage, mini clinics

A recent NRC Health "2016 U.S. Healthcare Consumer Insights" report examined online ratings and reviews on hospital websites from patients.

IBM, University of Alberta develop AI capable of predicting schizophrenia

Researchers at IBM and the University of Alberta have developed artificial intelligence (AI) algorithms capable of predicting schizophrenia with 74 percent accuracy.

Competition for pediatric medical devices offers $50,000 in prizes

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) has announced a competition to develop new technology for pediatric care. The competition will award up to six prizes of $50,000 for innovative medical devices.

10 steps to improving patient care with technology

Technology has become integral to providing high quality care, yet many healthcare organizations struggle with utilizing their technology in the most effective way. A recent list created by SCI Solutions, providers of patient care management technology, featured 10 checkpoints of success to help organizations improve care.

9 takeaways on clinical trials from the patient's view

In a recent survey conducted by Research!America and the Association of Clinical Research Organizations, researchers outline the views of the public in order to expand understanding of their views on health, research and technological utilization.

Hal Wolf announced as new CEO, president of HIMSS

Hal Wolf, previous director with the Chartis Group, has been announced as the new CEO at HIMSS. Wolf replaces Stephen Lieber who held the position for 17 years.

Q&A: Wolters Kluwer Health's Saghbini on potential improvements in health IT

As Wolters Kluwer Health's newly appointed vice president and chief technology officer, Jean-Claude Saghbini, MS, promises to develop new technologies and system improvements. In an exclusive interview with Clinical Innovation & Technology, Saghbini talks about the future healthcare technology, areas of improvement and plans for Wolters Kluwer Health.

More than half of neurology fellows experience burnout

A recent study, published in Neurology, found more than half of neurology fellows experience at least one symptom of burnout.

Virtual reality system recreates real-life tasks to improve patient development

Saebo, a producer of medical devices focused on engagement and development, has received clearance from the U.S. Food and Drug Administration (FDA) for its SaeboVR software system. The system is a rehabilitation program designed to use virtual reality to help patients engage in physical and cognitive activities.